| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 7,471 | $5.77 | $43,117.05 | -2.6% | |
| Jul 16, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 33,350 | $0.57 | $19,142.50 | - | |
| Jul 15, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $113.09 | $692,450.07 | -13.1% | |
| Jul 15, 2019 | LLY Eli Lilly & Co | Smiley Joshua L58 | SVP And CFO | Buy | 185 | $108.47 | $20,066.95 | +0.6% | |
| Jul 15, 2019 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 30,680 | $87.50 | $2,684,506.14 | -17.8% | |
| Jul 15, 2019 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 5,835 | $87.44 | $510,201.31 | -28.1% | |
| Jul 15, 2019 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 25,000 | $11.26 | $281,500.00 | -15.9% | |
| Jul 15, 2019 | HROW Harrow, Inc. | Kammer Robert J | Director | Sell | 6,500 | $7.91 | $51,415.00 | -0.8% | |
| Jul 11, 2019 | BHC Bausch Health Companies Inc. | Ackermann Christina | EVP And General Counsel | Sell | 3,968 | $24.81 | $98,446.08 | -6.0% | |
| Jul 11, 2019 | AMRN Amarin Corp Plc\uk | Stack David M67 | Director | Sell | 51,991 | $22.28 | $1,158,354.28 | -100% | |
| Jul 11, 2019 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 7,220 | $87.63 | $632,716.64 | -2.5% | |
| Jul 11, 2019 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 2,857 | $12.31 | $35,169.67 | -7.0% | |
| Jul 10, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 4,918 | $28.07 | $138,048.26 | -15.1% | |
| Jul 10, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 8,819 | $28.14 | $248,166.66 | -5.8% | |
| Jul 10, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 6,615 | $20.31 | $134,333.45 | -4.1% | |
| Jul 10, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 14,376 | $6.28 | $90,285.79 | -2.4% | |
| Jul 10, 2019 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 1,554 | $6.23 | $9,677.49 | +1.1% | |
| Jul 8, 2019 | RMTI Rockwell Medical, Inc. | Richmond David S. | 10% Owner, See Footnotes 1 And 2 | Buy | 9,780 | $3.05 | $29,787.92 | +1.9% | |
| Jul 8, 2019 | LNTH Lantheus Holdings, Inc. | Orlandi Cesare | Chief Medical Officer | Sell | 35,586 | $28.17 | $1,002,615.06 | -19.8% | |
| Jul 8, 2019 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 13,115 | $42.88 | $562,376.75 | -4.0% | |
| Jul 8, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 33,000 | $0.54 | $17,850.00 | - | |
| Jul 5, 2019 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Sell | 100,000 | $23.82 | $2,381,580.00 | -54.2% | |
| Jul 3, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $28.41 | $142,050.00 | -13.3% | |
| Jul 3, 2019 | AMRN Amarin Corp Plc\uk | Berg Aaron | Chief Commercial Officer | Sell | 98,814 | $21.30 | $2,104,378.43 | -43.4% | |
| Jul 1, 2019 | AMRN Amarin Corp Plc\uk | Kennedy Joseph T | General Counsel | Sell | 54,186 | $19.52 | $1,057,905.79 | -63.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.